Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Venmax Drugs & Pharmaceuticals Ltd.
₹26
₹26.00
₹26.00
Data is not available
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 1.55 | 1.32 | 1.21 | 0.33 | 0.20 |
| Operating Expense | 1.58 | 1.27 | 1.17 | 0.58 | 0.69 |
| Operating Profit | -0.02 | 0.05 | 0.04 | -0.25 | -0.49 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 0.01 | 0.02 | 0 | 0 | 0 |
| Net Profit | 0.03 | 0.02 | 0.04 | 0.78 | -0.50 |
₹26.00
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 23.1 | 23.1 | 23.1 | 23.1 | 23.1 | 15.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.2 | 0.2 | 0.2 | 0 | 0 | 0 |
| Public | 76.7 | 76.7 | 76.7 | 76.9 | 76.9 | 84.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 396 | 397 | 99.50% |
| Week | 287 | 296 | 96.79% |
| 1 Month | 796 | 876 | 90.83% |
| 6 Month | 2.46 K | 2.53 K | 97.19% |
Undervalued Growth Stocks
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹217 | ₹36.87 | ₹5.54 | ₹99.90 | ₹345.05 | ₹105.90 |
| % Change | 4.35% | 1.99% | 4.92% | 7.48% | -1.17% | 6.10% |
| Revenue TTM (₹ Cr) | - | ₹0.54 | ₹83.60 | - | - | ₹282.74 |
| Net Profit TTM (₹ Cr) | - | ₹-0.24 | ₹-34.95 | - | - | ₹15.30 |
| PE TTM | 60.10 | -91.90 | -1.30 | 12.30 | 77.30 | 25.30 |
| 1 Year Return | 703.33 | 428 | -27.38 | -20.79 | ||
| ROCE | - | - | -5.63 | - | - | - |
Anlon Healthcare Ltd.
₹ 112.54
+1.04%
Medistep Healthcare Ltd.
₹ 17.30
+4.85%
Patel Chem Specialities Ltd.
₹ 58.00
-5.97%
Asston Pharmaceuticals Ltd.
₹ 78.80
+7.95%
Influx Healthtech Ltd.
₹ 213.20
+5.54%
Gufic BioSciences Ltd.
₹ 285.00
+4.09%
Jagsonpal Pharmaceuticals Ltd.
₹ 186.00
+1.07%
Gujarat Themis Biosyn Ltd.
₹ 256.00
+12.83%
Makers Laboratories Ltd.
₹ 159.95
+18.31%
Unichem Laboratories Ltd.
₹ 297.95
+1.53%
Fermenta Biotech Ltd.
₹ 327.80
+2.74%
Anuh Pharma Ltd.
₹ 74.50
+11.19%
Bliss GVS Pharma Ltd.
₹ 229.65
+6.52%
Parnax Lab Ltd.
₹ 134.00
+4.24%
Novartis India Ltd.
₹ 1008.00
+3.83%
Morepen Laboratories Ltd.
₹ 37.25
+10.60%
Lyka Labs Ltd.
₹ 51.00
+13.46%
Ambalal Sarabhai Enterprises Ltd.
₹ 26.50
+9.19%
Accretion Pharmaceuticals Ltd.
₹ 66.70
+4.96%
Sat Kartar Shopping Ltd.
₹ 158.00
+5.16%
Onyx Biotec Ltd.
₹ 34.00
+0.00%
Vaishali Pharma Ltd.
₹ 5.85
+19.88%
Balaxi Pharmaceuticals Ltd.
₹ 18.80
+19.97%
Quest Laboratories Ltd.
₹ 102.35
-1.96%
By signing up I certify terms, conditions & privacy policy